Biogen Hires Pfizer Neuroscientist Michael Ehlers as R&D Chief

Biogen Inc. has hired Pfizer Inc.’s Michael Ehlers to be its new research and development chief, filling a vacancy at the biotechnology company that has been open for nine months. Ehlers, 47, will join Cambridge, Massachusetts-based Biogen in late May, the company said Wednesday in a statement. Ehlers was Pfizer’s group senior vice president for biotherapeutics R&D and chief scientific officer for the company’s neuroscience and pain research unit, which included work on programs in Alzheimer’s disease, Parkinson’s disease and schizophrenia. Before that, he was a neurobiology professor at Duke University Medical Center. “We scoured the globe, and we were committed to keeping the search going until we found a person who would be a great fit,” Biogen Chief Executive Officer George Scangos said in a phone interview. Ehlers is “not…

Link to Full Article: Biogen Hires Pfizer Neuroscientist Michael Ehlers as R&D Chief

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!